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Background
One of the advantages of CT angiography (CTA) over
MRA for transcatheter aortic valve replacement (TAVR)
planning is the ability to display aortic valve and arterial
calcification accurately. However, in many patients who
are TAVR candidates, renal impairment makes iodinated
contrast media undesirable or contraindicated. Further,
in patients with severe renal impairment, gadolinium
based contrast agents may be problematic because of the
perceived risk of NSF. We hypothesized that in patients
where ferumoxytol-enhanced MRA (FEMRA) is a suita-
ble alternative to CTA, vascular and valvular calcification
may be accurately displayed over luminal anatomy by
fusing non-contrast CT and FEMRA in these patients.
Methods
Nine patients who underwent FEMRA for assessment of
arterial access anatomy prior to TAVR had additional
non-contrast CT of the thorax and abdomen. CT and MR
DICOM data were processed in a commercially available
software (Mimics V17.0, Materialize) and the calcium
from the CT was isolated and registered to the FEMRA
data.
Results
In all cases, the calcification was fused successfully with
the 3D FEMRA data and volume rendered images were
generated showing the degree and distribution of calcifi-
cation clearly (figure 1), forming the basis for more con-
fident procedure planning.
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Figure 1 FEMRA (left), non-contrast CT (middle) and Volume rendered FEMRA with calcium overlay (right) in an 84 year old male
patient with calcific aortic stenosis who had successful TAVR placement.
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Conclusions
By fusing non-contrast CT and FEMRA, both luminal
anatomy and vascular calcification can be accurately
defined, addressing one of the main limitations of MR
over CT for TAVR planning.
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